Get the tools used by (smart)2 investors.
Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

ALIVUS: Alivus Life Sciences Ltd

Alivus Life Sciences Limited engages in the development, manufacture, and marketing of non-commoditized active pharmaceutical ingredients for various chronic therapeutic areas in India. The company of...

991.60 INR
Price
INR
Fair Value
Upside
743.85 - 1,335.10
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Alivus Life Sciences Ltd's P/E Ratio:

Mar 2016Mar 2018Mar 2020Mar 2022Mar 202412.0x16.0x20.0x

Performance Summary
  • Alivus Life Sciences's latest twelve months p/e ratio is 27.5x
  • Alivus Life Sciences's p/e ratio decreased in 2023 (11.5x, -13.3%) and increased in 2024 (18.3x, +59.7%).

How does Alivus Life Sciences's P/E Ratio benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Alivus Life Sciences Ltd because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: P/E Ratio

Hide this widget
pe_ltm
Slug
number
Datatype
text
Format
current
Default Period
FY, LTM
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to P/E Ratio in the valuation category include:

View Full List

Search for metric or datapoint

P/E Ratio

Indicates the multiple of earnings that stock investors are willing to pay for one share of the firm.

Definition of P/E Ratio

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-210.4x-60.4x89.6x300.5x0100200300

The chart above depicts the distribution of p/e ratio for companies operating in the Healthcare sector in the Developing economic region. Over 1,180 companies were considered in this analysis, and 1,139 had meaningful values. The average p/e ratio of companies in the sector is 22.3x with a standard deviation of 56.1x.

Alivus Life Sciences Ltd's P/E Ratio of 27.5x ranks in the 65.6% percentile for the sector. The following table provides additional summary stats:

P/E Ratio In The Healthcare Sector
Economic Risk RegionDeveloping
Total Constituents1,187
Included Constituents1,139
Min-202.1x
Max298.4x
Median18.7x
Mean22.3x
Standard Deviation56.1x

You can find companies with similar p/e ratio using this stock screener.

All rights reserved. Terms Of Use